• Atara hires ex-Genentech SVP to lead global R&D fiercebiotech
    May 08, 2018
    Atara Biotherapeutics has named Dietmar Berger, M.D., Ph.D., as its global head of R&D. Berger joins after seven years at Roche’s Genentech, during which time he had a hand in the approval of drugs including PD-L1 checkpoint inhibitor Tecentriq.
PharmaSources Customer Service